0001769029-20-000002.txt : 20200624 0001769029-20-000002.hdr.sgml : 20200624 20200624111654 ACCESSION NUMBER: 0001769029-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 EFFECTIVENESS DATE: 20200624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abfero Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001769029 IRS NUMBER: 811705490 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369580 FILM NUMBER: 20984421 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET STREET 2: SUITE 353 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 7812667297 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET STREET 2: SUITE 353 CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001769029 Abfero Pharmaceuticals, Inc. 405 WALTHAM STREET SUITE 353 LEXINGTON MA MASSACHUSETTS 02421 7812667297 DELAWARE None None Corporation true 2016 Thomas X. Neenan 405 Waltham Street Suite 353 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Steven Burke 405 Waltham Street Suite 353 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Michael Penington 405 Waltham Street Suite 353 Lexington MA MASSACHUSETTS 02421 Director Biotechnology Decline to Disclose 06b false 2020-06-12 false true false 30000 2000000 680000 1320000 false 4 0 0 270000 true false Abfero Pharmaceuticals, Inc. \s\ Thomas X. Neenan Thomas X. Neenan President 2020-06-23